Literature DB >> 11989622

Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.

A Bronowska1, Z Chilmonczyk, A Leś, O Edvardsen, R Ostensen, I Sylte.   

Abstract

In the present study experimentally determined ligand selectivity of three methylated buspirone analogues (denoted as MM2, MM5 and P55) towards 5-HT1A and 5-HT2A serotonin receptors was theoretically investigated on a molecular level. The relationships between the ligand structure and 5-HT1A and 5-HT2A receptor affinities were studied and the results were found to be in agreement with the available site-directed mutagenesis and binding affinity data. Molecular dynamics (MD) simulations of ligand-receptor complexes were performed for each investigated analogue, docked twice into the central cavity of 5-HT1A/5-HT2A, each time in a different orientation. Present results were compared with our previous theoretical results, obtained for buspirone and its non-methylated analogues. It was found that due to the presence of the methyl group in the piperazine ring the ligand position alters and the structure of the ligand-receptor complex is modified. Further, the positions of derivatives with pyrimidinyl aromatic moiety and quinolinyl moiety are significantly different at the 5-HT2A receptor. Thus, methylation of such derivatives alters the 3D structures of ligand-receptor complexes in different ways. The ligand-induced changes of the receptor structures were also analysed. The obtained results suggest, that helical domains of both receptors have different dynamical behaviour. Moreover, both location and topography of putative binding sites for buspirone analogues are different at 5-HT1A and 5-HT2A receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11989622     DOI: 10.1023/a:1014856107486

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  61 in total

1.  Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors.

Authors:  B L Roth; M Shoham; M S Choudhary; N Khan
Journal:  Mol Pharmacol       Date:  1997-08       Impact factor: 4.436

2.  Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin.

Authors:  D L Farrens; C Altenbach; K Yang; W L Hubbell; H G Khorana
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

3.  Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression.

Authors:  D S Robinson; K Rickels; J Feighner; L F Fabre; R E Gammans; R C Shrotriya; D R Alms; J J Andary; M E Messina
Journal:  J Clin Psychopharmacol       Date:  1990-06       Impact factor: 3.153

4.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

Authors:  P Samama; S Cotecchia; T Costa; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

5.  Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors.

Authors:  Zdzisław Chilmonczyk; Marcin Cybulski; Joanna Iskra-Jopa; Ewa Chojnacka-Wójcik; Ewa Tatarczyńska; Aleksandra Kłodzińska; Andrzej Leś; Agnieszka Bronowska; Ingebrigt Sylte
Journal:  Farmaco       Date:  2002-04

6.  Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity.

Authors:  C A Stockmeier; L A Shapiro; G E Dilley; T N Kolli; L Friedman; G Rajkowska
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor.

Authors:  E H Cook; K E Fletcher; M Wainwright; N Marks; S Y Yan; B L Leventhal
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

8.  Identification of a Gs coupling domain in the amino terminus of the third intracellular loop of the alpha 2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling.

Authors:  M G Eason; S B Liggett
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

Review 9.  Buspirone use for smoking cessation.

Authors:  P Farid; M A Abate
Journal:  Ann Pharmacother       Date:  1998-12       Impact factor: 3.154

10.  Binding of antidepressants to human brain receptors: focus on newer generation compounds.

Authors:  B Cusack; A Nelson; E Richelson
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

View more
  2 in total

1.  Key issues in the computational simulation of GPCR function: representation of loop domains.

Authors:  E L Mehler; X Periole; S A Hassan; H Weinstein
Journal:  J Comput Aided Mol Des       Date:  2002-11       Impact factor: 3.686

Review 2.  Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier.

Authors:  David Lee; Tamara Minko
Journal:  Pharmaceutics       Date:  2021-11-30       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.